Hempshire Group Geçmiş Kazanç Performansı
Geçmiş kriter kontrolleri 0/6
Hempshire Group has been growing earnings at an average annual rate of 61.6%, while the Pharmaceuticals industry saw earnings growing at 46% annually. Revenues have been growing at an average rate of 42.2% per year.
Anahtar bilgiler
61.6%
Kazanç büyüme oranı
71.8%
EPS büyüme oranı
| Pharmaceuticals Sektör Büyümesi | 23.1% |
| Gelir büyüme oranı | 42.2% |
| Özkaynak getirisi | n/a |
| Net Marj | -1,265.1% |
| Son Kazanç Güncellemesi | 30 Sep 2023 |
Yakın geçmiş performans güncellemeleri
Recent updates
Gelir ve Gider Dağılımı
Hempshire Group nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.
Kazanç ve Gelir Geçmişi
| Tarih | Gelir | Kazançlar | G+A Giderleri | Ar-Ge Giderleri |
|---|---|---|---|---|
| 30 Sep 23 | 0 | -2 | 2 | 0 |
| 30 Jun 23 | 0 | -3 | 2 | 0 |
| 31 Mar 23 | 0 | -6 | 2 | 0 |
| 31 Dec 22 | 0 | -7 | 2 | 0 |
| 30 Sep 22 | 0 | -7 | 2 | 0 |
| 30 Jun 22 | 0 | -6 | 2 | 0 |
| 31 Mar 22 | 0 | -3 | 2 | 0 |
| 31 Dec 21 | 0 | -2 | 2 | 0 |
| 31 Dec 20 | 0 | 0 | 0 | 0 |
Kaliteli Kazançlar: HMPG is currently unprofitable.
Büyüyen Kar Marjı: HMPG is currently unprofitable.
Serbest Nakit Akışı ve Kazanç Analizi
Geçmiş Kazanç Büyüme Analizi
Kazanç Eğilimi: Insufficient data to determine if HMPG's year-on-year earnings growth rate was positive over the past 5 years.
Büyüme Hızlandırma: Unable to compare HMPG's earnings growth over the past year to its 5-year average as it is currently unprofitable
Kazançlar vs. Sektör: HMPG is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (-40.8%).
Özkaynak Getirisi
Yüksek ROE: HMPG's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.